Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/31995683/ below:

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

Randomized Controlled Trial

Affiliations

• ¹ From the Departments of Public Health (H.J.K., C.M.A., U.Y.-K., K.H.) and Pulmonology (J.G.J.V.A.), Erasmus MC-University Medical Center Rotterdam, and the Departments of Pulmonology (S.W.) and Pathology (M.A.B.), Maasstad Hospital, Rotterdam, the Departments of Radiology (P.A.J., W.P.M., F.A.A.M.H.) and Pulmonology (J.-W.J.L.), University Medical Center Utrecht, Utrecht, the Departments of Radiology (E.T.S.) and Pulmonology (C.W.), Spaarne Gasthuis, Haarlem, the Department of Radiation Oncology, Leiden University Medical Center, Leiden (N.H.), the Faculty of Medical Sciences (M.A.H., J.E.W., M.O.), the Data Science Center in Health (P.M.A.O.), and the Departments of Radiology (R.V.) and Pulmonology (H.J.M.G), University of Groningen-University Medical Center Groningen, and the Institute for DiagNostic Accuracy (J.E.W., M.O.), Groningen, the Department of Radiology, Radboud University Medical Center, Nijmegen (M.P.), and the Department of Pathology, University Medical Center Amsterdam, Amsterdam (E.T.) - all in the Netherlands; and the Departments of Pulmonology (K.N.) and Radiology (J.V.), KU Leuven, University Hospital, Leuven, Belgium.

• PMID: 31995683
• DOI: 10.1056/NEJMoa1911793

Item in Clipboard

Randomized Controlled Trial

Harry J de Koning et al. N Engl J Med. 2020.

• ¹ From the Departments of Public Health (H.J.K., C.M.A., U.Y.-K., K.H.) and Pulmonology (J.G.J.V.A.), Erasmus MC-University Medical Center Rotterdam, and the Departments of Pulmonology (S.W.) and Pathology (M.A.B.), Maasstad Hospital, Rotterdam, the Departments of Radiology (P.A.J., W.P.M., F.A.A.M.H.) and Pulmonology (J.-W.J.L.), University Medical Center Utrecht, Utrecht, the Departments of Radiology (E.T.S.) and Pulmonology (C.W.), Spaarne Gasthuis, Haarlem, the Department of Radiation Oncology, Leiden University Medical Center, Leiden (N.H.), the Faculty of Medical Sciences (M.A.H., J.E.W., M.O.), the Data Science Center in Health (P.M.A.O.), and the Departments of Radiology (R.V.) and Pulmonology (H.J.M.G), University of Groningen-University Medical Center Groningen, and the Institute for DiagNostic Accuracy (J.E.W., M.O.), Groningen, the Department of Radiology, Radboud University Medical Center, Nijmegen (M.P.), and the Department of Pathology, University Medical Center Amsterdam, Amsterdam (E.T.) - all in the Netherlands; and the Departments of Pulmonology (K.N.) and Radiology (J.V.), KU Leuven, University Hospital, Leuven, Belgium.

• PMID: 31995683
• DOI: 10.1056/NEJMoa1911793

Item in Clipboard

Background: There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.

Methods: A total of 13,195 men (primary analysis) and 2594 women (subgroup analyses) between the ages of 50 and 74 were randomly assigned to undergo CT screening at T0 (baseline), year 1, year 3, and year 5.5 or no screening. We obtained data on cancer diagnosis and the date and cause of death through linkages with national registries in the Netherlands and Belgium, and a review committee confirmed lung cancer as the cause of death when possible. A minimum follow-up of 10 years until December 31, 2015, was completed for all participants.

Results: Among men, the average adherence to CT screening was 90.0%. On average, 9.2% of the screened participants underwent at least one additional CT scan (initially indeterminate). The overall referral rate for suspicious nodules was 2.1%. At 10 years of follow-up, the incidence of lung cancer was 5.58 cases per 1000 person-years in the screening group and 4.91 cases per 1000 person-years in the control group; lung-cancer mortality was 2.50 deaths per 1000 person-years and 3.30 deaths per 1000 person-years, respectively. The cumulative rate ratio for death from lung cancer at 10 years was 0.76 (95% confidence interval [CI], 0.61 to 0.94; P = 0.01) in the screening group as compared with the control group, similar to the values at years 8 and 9. Among women, the rate ratio was 0.67 (95% CI, 0.38 to 1.14) at 10 years of follow-up, with values of 0.41 to 0.52 in years 7 through 9.

Conclusions: In this trial involving high-risk persons, lung-cancer mortality was significantly lower among those who underwent volume CT screening than among those who underwent no screening. There were low rates of follow-up procedures for results suggestive of lung cancer. (Funded by the Netherlands Organization of Health Research and Development and others; NELSON Netherlands Trial Register number, NL580.).

Copyright © 2020 Massachusetts Medical Society.

PubMed Disclaimer

• Mortality Reduction with Low-Dose CT Screening for Lung Cancer.

  Duffy SW, Field JK. Duffy SW, et al. N Engl J Med. 2020 Feb 6;382(6):572-573. doi: 10.1056/NEJMe1916361. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995680 No abstract available.

• NELSON updated.

  Romero D. Romero D. Nat Rev Clin Oncol. 2020 Apr;17(4):197. doi: 10.1038/s41571-020-0342-x. Nat Rev Clin Oncol. 2020. PMID: 32060417 No abstract available.

• [Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?].

  Lanthier L, Bouchard N, Huard G, Plourde ME, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 May;41(5):350-351. doi: 10.1016/j.revmed.2020.04.001. Epub 2020 Apr 17. Rev Med Interne. 2020. PMID: 32312589 French. No abstract available.

• Lung-Cancer Screening and the NELSON Trial.

  Lindholt JS, Søgaard R. Lindholt JS, et al. N Engl J Med. 2020 May 28;382(22):2164. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459929 No abstract available.

• Lung-Cancer Screening and the NELSON Trial.

  Kennedy MP. Kennedy MP. N Engl J Med. 2020 May 28;382(22):2164-2165. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459930 No abstract available.

• Lung-Cancer Screening and the NELSON Trial.

  Autier P. Autier P. N Engl J Med. 2020 May 28;382(22):2165. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459931 No abstract available.

• Lung Cancer Screening with Chest CT: Efficacy Confirmed.

  Tailor TD, Patz EF Jr. Tailor TD, et al. Radiol Imaging Cancer. 2020 May 29;2(3):e204015. doi: 10.1148/rycan.2020204015. eCollection 2020 May. Radiol Imaging Cancer. 2020. PMID: 33778718 Free PMC article. No abstract available.

• Novelties in Lung Cancer Screening.

  Mai V, Quigley N, Roy P, Labbé C. Mai V, et al. Am J Respir Crit Care Med. 2021 Sep 1;204(5):596-598. doi: 10.1164/rccm.202012-4505RR. Am J Respir Crit Care Med. 2021. PMID: 34213386 No abstract available.

• Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

  Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, Ten Haaf K, Yousaf-Khan U, van der Aalst CM, de Bock GH, Mali W, Groen HJM, de Koning HJ, Oudkerk M. Walter JE, et al. Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283862 Clinical Trial.

• Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M, Middleton JC, Voisin C, Harris RP. Jonas DE, et al. JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377. JAMA. 2021. PMID: 33687468

• Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

  Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ. Horeweg N, et al. Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282284 Clinical Trial.

• Lung Cancer Screening in the Community Setting.

  Cattaneo SM 2nd, Meisenberg BR, Geronimo MCM, Bhandari B, Maxted JW, Brady-Copertino CJ. Cattaneo SM 2nd, et al. Ann Thorac Surg. 2018 Jun;105(6):1627-1632. doi: 10.1016/j.athoracsur.2018.01.075. Epub 2018 Mar 1. Ann Thorac Surg. 2018. PMID: 29501646 Review.

• Lung cancer screening: Current status and perspective.

  Chassagnon G, Revel MP. Chassagnon G, et al. Diagn Interv Imaging. 2016 Oct;97(10):949-953. doi: 10.1016/j.diii.2016.06.018. Epub 2016 Aug 12. Diagn Interv Imaging. 2016. PMID: 27527243 Review.

• Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.

  Eyestone E, Williams RM, Luta G, Kim E, Toll BA, Rojewski A, Neil J, Cinciripini PM, Cordon M, Foley K, Haas JS, Joseph AM, Minnix JA, Ostroff JS, Park E, Rigotti N, Sorgen L, Taylor KL. Eyestone E, et al. Nicotine Tob Res. 2021 Nov 5;23(12):2037-2046. doi: 10.1093/ntr/ntab110. Nicotine Tob Res. 2021. PMID: 34077535 Free PMC article.

• The Value of PETRA in Pulmonary Nodules of <3 cm Among Patients With Lung Cancer.

  Feng H, Shi G, Liu H, Du Y, Zhang N, Wang Y. Feng H, et al. Front Oncol. 2021 May 18;11:649625. doi: 10.3389/fonc.2021.649625. eCollection 2021. Front Oncol. 2021. PMID: 34084745 Free PMC article.

• Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images.

  Liao RQ, Li AW, Yan HH, Lin JT, Liu SY, Wang JW, Fang JS, Liu HB, Hou YH, Song C, Yang HF, Li B, Jiang BY, Dong S, Nie Q, Zhong WZ, Wu YL, Yang XN. Liao RQ, et al. Front Oncol. 2022 Oct 12;12:1002953. doi: 10.3389/fonc.2022.1002953. eCollection 2022. Front Oncol. 2022. PMID: 36313666 Free PMC article.

• Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.

  Chen X, Dong Z, Hubbell E, Kurtzman KN, Oxnard GR, Venn O, Melton C, Clarke CA, Shaknovich R, Ma T, Meixiong G, Seiden MV, Klein EA, Fung ET, Liu MC. Chen X, et al. Clin Cancer Res. 2021 Aug 1;27(15):4221-4229. doi: 10.1158/1078-0432.CCR-21-0417. Epub 2021 Jun 4. Clin Cancer Res. 2021. PMID: 34088722 Free PMC article.

• Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking.

  Chatzidionysiou K, di Giuseppe D, Soderling J, Catrina A, Askling J. Chatzidionysiou K, et al. RMD Open. 2022 Oct;8(2):e002465. doi: 10.1136/rmdopen-2022-002465. RMD Open. 2022. PMID: 36270743 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3